SCHEMBL231498

SCHEMBL231498

OCC1(CBr)COC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9389885 0.87 EPHX1 (0.43)
SCHEMBL693632 0.82
SCHEMBL521656 0.82
SCHEMBL8841197 0.79
SCHEMBL3831102 0.79 EPHX1 (0.36)
SCHEMBL9214313 0.77 EPHX1 (0.33)
SCHEMBL25254403 0.77 EPHX1 (0.52)
SCHEMBL12769174 0.75 EPHX1 (0.41)
SCHEMBL9150386 0.73
SCHEMBL14896011 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 297 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3097098-B1 PROCESS FOR THE PREPARATION OF N-[(3-AMINOOXETAN-3-YL)METHYL]-2-(1,1-DIOXO-3,5-DIHYDRO-1,4-BENZOTHIAZEPIN-4-YL)-6-METHYL-QUINAZOLIN-4-AMINE HOFFMANN LA ROCHE (CH) 2020-03-04 EP claimed
US-10005770-B2 Process for the preparation of N-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxo-3,5-dihydro-1,4-benzothiazepin-4-yl)-6-methyl-quinazolin-4-amine HOFFMANN-LA ROCHE INC. (US) 2018-06-26 US claimed
EP-3097098-A1 PROCESS FOR THE PREPARATION OF N-[(3-AMINOOXETAN-3-YL)METHYL]-2-(1,1-DIOXO-3,5-DIHYDRO-1,4-BENZOTHIAZEPIN-4-YL)-6-METHYL-QUINAZOLIN-4-AMINE F. Hoffmann-La Roche AG (CH) 2016-11-30 EP claimed
US-20160326160-A1 PROCESS FOR THE PREPARATION OF N-[(3-AMINOOXETAN-3-YL)METHYL]-2-(1,1-DIOXO-3,5-DIHYDRO-1,4-BENZOTHIAZEPIN-4-YL)-6-METHYL-QUINAZOLIN-4-AMINE HOFFMANN-LA ROCHE INC. (US) 2016-11-10 US claimed
WO-2015110446-A1 PROCESS FOR THE PREPARATION OF N-[(3-AMINOOXETAN-3-YL)METHYL]-2-(1,1-DIOXO-3,5-DIHYDRO-1,4-BENZOTHIAZEPIN-4-YL)-6-METHYL-QUINAZOLIN-4-AMINE F. HOFFMANN-LA ROCHE AG (CH) 2015-07-30 WO claimed
US-20080121845-A1 Oxetane composition, associated method and article GENERAL ELECTRIC COMPANY (US) 2008-05-29 US claimed
US-20080039608-A1 Oxetane composition, associated method and article GENERAL ELECTRIC COMPANY (US) 2008-02-14 US claimed
WO-2008019149-A1 COMPOSITION AND ASSOCIATED METHOD MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2008-02-14 WO claimed
WO-2008019151-A1 OXETANE COMPOSITION, ASSOCIATED METHOD AND ARTICLE MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2008-02-14 WO claimed
US-20080039542-A1 Composition and associated method GENERAL ELECTRIC COMPANY (US) 2008-02-14 US claimed
US-20260137706-A1 METHODS OF TREATING INFLAMMATORY DISEASES INTERLINE THERAPEUTICS INC (US) 2026-05-21 US disclosed
CN-122070282-A Pyrazole-1-carboxamides as RIP1 kinase inhibitors 比西切姆有限公司 2026-05-19 CN disclosed
US-20260103471-A1 CYCLIC UREA THIAZOLYL COMPOUNDS FOR TREATMENT OF HSV ASSEMBLY BIOSCIENCES INC (US) 2026-04-16 US disclosed
EP-4724440-A1 METHODS OF TREATING INFLAMMATORY DISEASES Interline Therapeutics, Inc. (US) 2026-04-15 EP disclosed
US-20250376478-A1 CYCLIC UREA THIAZOLYL COMPOUNDS FOR TREATMENT OF HSV ASSEMBLY BIOSCIENCES INC (US) 2025-12-11 US disclosed
EP-0165636-B1 PROCESS FOR PREPARING AZETIDINE DERIVATIVES AND INTERMEDIATES THEREIN SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-08-10 EP disclosed
EP-0165637-B1 AZETIDINE DERIVATIVES SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-07-27 EP disclosed
US-4665197-A NITRIC ACID OXIDATION OF 3,3-BIS/HYDROXYMETHYL/AZETIDINE/ SHELL OIL COMPANY (US) 1987-05-12 US disclosed
EP-0165637-A1 Azetidine derivatives SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1985-12-27 EP disclosed
EP-0165636-A1 Process for preparing azetidine derivatives and intermediates therein SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1985-12-27 EP disclosed